Metacognitive therapy self-help for anxiety-depression: Single-blind randomized feasibility trial in cardiovascular disease
- PMID: 35467904
- PMCID: PMC9037049
- DOI: 10.1037/hea0001168
Metacognitive therapy self-help for anxiety-depression: Single-blind randomized feasibility trial in cardiovascular disease
Abstract
Background: One in three cardiovascular disease (CVD) patients experience significant anxiety and depression. Current psychological interventions have limited efficacy in reducing such symptoms and are offered as a face-to-face intervention that may be a barrier to accessing treatment. We evaluated the feasibility and acceptability of delivering assisted home-based self-help metacognitive therapy (home-MCT) to cardiac rehabilitation (CR) patients experiencing anxiety and depression.
Method: One hundred eight CR patients with elevated anxiety and/or depression were recruited to a single-blind randomized feasibility trial across two United Kingdom National Health Service Trusts and were randomized to usual CR or usual CR plus home-MCT. The feasibility and acceptability of adding home-MCT to CR was based on credibility or expectancy ratings, recruitment rate, drop-outs, number of CR and home-MCT modules completed, and ability of outcome measures to discriminate between patients. The study was used to refine the sample size estimate for a full-scale trial. The quality of telephone support calls delivered by CR staff trained in MCT was assessed.
Results: Home-MCT was found to be feasible and acceptable for the current CR patients with anxiety and depression. Recruitment and retention of participants was high, and attendance at CR was similar for both groups. Completion of home-MCT was high, but the quality of telephone support calls delivered was lower than expected.
Conclusions: Home-MCT was acceptable and feasible to deliver to CR patients experiencing anxiety and depression, and the feasibility of conducting a full-scale trial of the intervention was established. Home-MCT may provide additional treatment options for cardiac patients experiencing psychological distress. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Figures



Similar articles
-
Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial.PLoS Med. 2023 Jan 31;20(1):e1004161. doi: 10.1371/journal.pmed.1004161. eCollection 2023 Jan. PLoS Med. 2023. PMID: 36719886 Free PMC article. Clinical Trial.
-
Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme.Front Psychiatry. 2022 Jun 3;13:886407. doi: 10.3389/fpsyt.2022.886407. eCollection 2022. Front Psychiatry. 2022. PMID: 35722590 Free PMC article. Review.
-
Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT).Trials. 2018 Aug 16;19(1):444. doi: 10.1186/s13063-018-2826-x. Trials. 2018. PMID: 30115112 Free PMC article. Clinical Trial.
-
Establishing the Feasibility of Group Metacognitive Therapy for Anxiety and Depression in Cardiac Rehabilitation: A Single-Blind Randomized Pilot Study.Front Psychiatry. 2020 Jun 30;11:582. doi: 10.3389/fpsyt.2020.00582. eCollection 2020. Front Psychiatry. 2020. PMID: 32714216 Free PMC article.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
Cited by
-
Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation.Cochrane Database Syst Rev. 2024 Apr 5;4(4):CD013508. doi: 10.1002/14651858.CD013508.pub3. Cochrane Database Syst Rev. 2024. PMID: 38577875 Free PMC article.
-
Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial.PLoS Med. 2023 Jan 31;20(1):e1004161. doi: 10.1371/journal.pmed.1004161. eCollection 2023 Jan. PLoS Med. 2023. PMID: 36719886 Free PMC article. Clinical Trial.
-
Attention training technique delivered in groups as treatment for anxiety and depression in patients with coronary heart disease: study protocol for a waiting-list randomized controlled trial.Front Psychol. 2023 Sep 18;14:1226539. doi: 10.3389/fpsyg.2023.1226539. eCollection 2023. Front Psychol. 2023. PMID: 37790218 Free PMC article.
-
Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme.Front Psychiatry. 2022 Jun 3;13:886407. doi: 10.3389/fpsyt.2022.886407. eCollection 2022. Front Psychiatry. 2022. PMID: 35722590 Free PMC article. Review.
-
Improving mental well-being in psychocardiology-a feasibility trial for a non-blended web application as a brief metacognitive-based intervention in cardiovascular disease patients.Front Psychiatry. 2023 Sep 28;14:1138475. doi: 10.3389/fpsyt.2023.1138475. eCollection 2023. Front Psychiatry. 2023. PMID: 37840797 Free PMC article.
References
-
- Beck J. G., Grant D. M., Read J. P., Clapp J. D., Coffey S. F., Miller L. M., & Palyo S. A. (2008). The impact of event scale-revised: Psychometric properties in a sample of motor vehicle accident survivors. Journal of Anxiety Disorders, 22(2), 187–198. 10.1016/j.janxdis.2007.02.007 - DOI - PMC - PubMed